MarketPeel
Insider Trading Intelligence
JN

James W. Jr. Newman

ADIL
DIRECTOR · ADIAL PHARMACEUTICALS, INC. · CIK 0001718364
FILING MIX · LIFETIME100%/0%
BUYS
15
SELLS
0
TOTAL VALUE
$122.6K
COMPANIES
1
ACTIVE SINCE
Mar 2020
HOLDINGS NOW
28,000
AVG SELL PX
TRADE KIND
SHOWING 15 / 15
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
7 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by James W. Jr. Newman, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d7+0.00%-7.02%-1.79%-5.22%-5.11%
14d7+0.00%-7.18%+3.51%-10.69%-6.07%
30d7+42.86%-7.38%+3.23%-10.61%-11.72%
60d7+42.86%-5.77%+3.45%-9.21%-14.54%
90d7+42.86%-11.01%+7.00%-18.01%-17.16%
180d7+0.00%-35.29%+1.99%-37.29%-38.59%
1y7+42.86%-20.92%+15.74%-36.66%-73.57%
2y7+42.86%-37.21%+38.10%-75.31%-99.22%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ADIL · 28,000 shares · as of May 29, 2025
038,24176,482114,722152,96320212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
FLOW · 15 buys / 0 sellsCOVERAGE · 22 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
28,00028,000May 29, 2025Jun 2, 2025View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,00012,000Mar 25, 2024Mar 27, 2024View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
50,00050,000May 23, 2023May 25, 2023View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Feb 23, 2022Feb 24, 2022View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASE
10,000$2.71$27.1K34,644Dec 30, 2021Jan 3, 2022View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASE
10,000$2.66$26.6K20,000Dec 30, 2021Jan 3, 2022View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASE
5,000$2.72$13.6K50,221Dec 30, 2021Jan 3, 2022View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASE
10,000$2.85$28.5K34,475Nov 26, 2021Nov 30, 2021View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Feb 8, 2021Feb 10, 2021View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
2,544152,963Jan 26, 2021Jan 28, 2021View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
1,18714,475Jan 26, 2021Jan 28, 2021View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASE
10,000$1.34$13.4K13,288Mar 27, 2020Mar 30, 2020View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASE
4,644$1.35$6.3K14,644Mar 27, 2020Mar 30, 2020View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASE
5,000$1.42$7.1K15,000Mar 27, 2020Mar 30, 2020View →
ADIL
ADIAL PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Mar 3, 2020Mar 5, 2020View →
Other insiders · ADIL
Loading peer insiders…
About this filer
CIK 0001718364
ROLE
Director
PRIMARY
ADIL
COMPANIES
1
ACTIVE SINCE
Mar 2020
MARKETPEEL · /INSIDER/0001718364DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback